• Investment themes.

Capital protected multi-niche strategy.

Our approach is of low risk and high margin in carefully chosen niches. We focus on global regions where we hold significant market expertise and have access to a ready supply of highly rated debtors.

  • Spain

    Credit insured, licensed and regulated Intra-Spain Pharma trade.

  • EU

    Credit insured imports to Europe.

  • Sweden

    Insured selected platform generated trades.

  • Africa (Q4 2023)

    Selected niche opportunities.

  • Brazil (Q1 2024)

    Cross-border SME exports and imports (2 independent strategies)


High-yield trade finance to a selected number of Pharma traders/clients, with a repayment period usually not exceeding 90 calendar days.

Our focus is on a small number of clients, which enables us to gain an ever-increasingly deep and time-served knowledge of their businesses. This knowledge allows us to understand and mitigate the risks being taken by the clients and, thereby, by ourselves.

We are a secured lender, receiving an absolute monetary return from the trade margin within a defined period. Our investment is protected through (a) ownership of the goods (b) credit insurance, and (c) a promissory note.